EquityBulls

Latest News

Keywords Selected: Lupin

Research

Lupin - Q1FY23 Result Update - Margin disappointment continues - HOLD

Stock Report

Lupin announces Successful Completion of UK MHRA Inspection of its Pithampur Facilities
Lupin announces completion of Pharmacovigilance Inspection by the U.S. FDA with No Observations
Lupin receives tentative approval from U.S. FDA for Obeticholic Acid Tablets
Lupin receives approval from US FDA for Brexpiprazole Tablets
Lupin's Alliance Partner Caplin Receives U.S. FDA Approval for Thiamine Hydrochloride Injection USP
Lupin Digital Health Unveils Results of India's First Digital Therapeutics Study with ACS Patients
Lupin Bioresearch Centre Completes U.S. FDA Inspection with No Observations
U.S. FDA Completes Inspection of Lupin's Vizag Facility with No Observations
Lupin Diagnostics Expands Presence in South India with New Regional Reference Laboratory in Hyderabad
Lupin Launches Lurasidone Hydrochloride Tablets in the United States
Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur
Lupin Ltd reports QoQ increase in consolidated PAT to Rs. 153.47 crores
Lupin receives approval from US FDA for Glycopyrrolate Injection, USP
Lupin Launches Aptivate Champion Run for Kids Promoting Well-being and Good Eating Habits
Lupin receives Tentative Approval from U.S. FDA for Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablets
Lupin Launches LYFE, its Digital Therapeutic Solution for Holistic Heart Care
Lupin Launches Sacubitril and Valsartan Combination Drug for Heart Failure Patients
Lupin receives Tentative Approval from U.S. FDA for Dolutegravir and Rilpivirine Tablets
Lupin gets 2 observations from USFDA for Somerset facility
Lupin receives approval from U.S. FDA for Prasugrel Tablets, USP
Lupin and Exeltis announce Reimbursement Approval of NaMuscla® in Spain
Lupin receives approval from U.S. FDA for Fesoterodine Fumarate Extended-Release Tablets
Lupin Launches novel fixed-dose triple drug combination DIFIZMA® DPI to Treat Inadequately Controlled Asthma
Lupin Diagnostics expands its footprint in Central India, Launches Regional Reference Laboratory in Indore